JACC Heart Failure

译名:JACC-心力衰竭

JACC-Heart Failure

SCIEJCR Q1

10-15

2026

影响因子区间

平台估算

投稿周期

3%

2025

中国作者发文占比

1969 USD

费用说明

收费

期刊简介:JACC: Heart Failure publishes the most important findings on the pathophysiology, diagnosis, treatment, and care of heart failure patients. The goal of the Journal is to improve our understanding of the disease, clinical trial, clinical outcomes, and advances in therapies through timely, insightful scientific communication. The Journal embraces interdisciplinary relationships with neuroscience, pulmonary medicine, nephrology, electrophysiology, and surgery as they relate to heart failure. In addition, the Journal includes articles concerning pharmacogenetics, biomarkers, and metabolomics.

【译文】JACC: 心力衰竭期刊发表关于心力衰竭患者病理生理学、诊断、治疗和护理的重要发现。该期刊的目标是通过及时、有洞察力的科学交流,提高我们对疾病、临床试验、临床结果和治疗进展的理解。该期刊与神经科学、肺病学、肾脏病学、电生理学和外科在心力衰竭相关领域建立了跨学科关系。此外,该期刊还包括关于药代遗传学、生物标志物和代谢组学的文章。

出版社
Elsevier BV
语言
English
学科
医学
ISSN
2213-1779
eISSN
2213-1787
出版频率
月刊
创刊年份
2014
投稿网址
https://www.elsevier.com/journals/jacc-heart-failure/2213-1779/guide-for-authors
最近更新
2026-04-02 18:16:40
JACC Heart Failure

指标当前值近三年趋势
JCR分区Q1
暂无
影响因子区间10-15
暂无